To contextualize the potential impact of GM-CSF-mediated priming of neutrophil function in the setting of BTK deficiency in vivo, we harvested neutrophils from a patient with XLA before and at different time-points after initiation of GM-CSF treatment. Here, CSF2 is linked to Bruton-type agammaglobulinemia.